Skip to content
Header Image
Market Spectator

Market Spectator

  • Business
  • Domestic
  • Economy
  • Politics
  • Top News
  • Newsletters
  • Home
  • 2024
  • March
  • 8
  • US FDA approves Novo Nordisk’s Wegovy for lowering heart risks
  • Boxes of Wegovy lie beside a packaging line at Novo

Boxes of Wegovy lie beside a packaging line at Novo

Boxes of Wegovy lie beside a packaging line at Novo Nordisk’s facility in Hillerod, Denmark, March 8, 2024. REUTERS/Tom Little

Post navigation

US FDA approves Novo Nordisk’s Wegovy for lowering heart risks

Live Market Pulse

The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

Categories

  • Business
  • Domestic
  • Economy
  • Politics
  • Top News
  • Uncategorized

Recent Posts

  • European drinks group skid after US surgeon general calls for cancer warnings
  • AI a productivity boost to banks but making money from it is a challenge
  • Adobe forecasts fiscal 2025 revenue below estimates on slower subscription spending
  • Microsoft expects $800 million impairment charge in Q2 2025 over General Motors’ Cruise exit
  • Stunning rally in Big Tech drives Nasdaq to 20,000
  • Home
  • Terms of Service
  • Privacy Policy
  • Disclaimer
  • Contact Us

Copyright © 2025 Market Spectator | Ace News Child IMS by Ascendoor | Powered by WordPress.